Recently unlocked door: a fresh permission, approval, or qualification is already producing first real business
The model's full reasoning — Q3 2021 call → NOWe need answer YES or NO based on transcript. Need identify if management describes recently obtained permission/approval/qualification/certification/listing/access right not previously held, granted by outside authority/customer/partner/institution, that newly allows company to sell/serve/operate where previously could not, AND real first business through that newly opened door has already begun, with most of what access permits still ahead. Let's parse transcript. Management discusses various contracts, opportunities. Need one coherent development with all three: (1) access real and recently in hand (granted within last few quarters), (2) first business already flowing, (3) management conveys large relative to what has flowed so far. What candidates? New lease agreement with State of New Mexico for Northwest New Mexico Correctional Center. They announced in September, commenced November 1, transitioned operations to state. That's a lease agreement—not exactly permission to sell? It is a new contract/access to operate? Wait, it's reclassifying from safety to property. It's a lease, not new business selling? But it allows company to lease facility to state; first rent? Commenced November 1, so business has begun. But is it large relative to what has flowed? It's a small facility with $3.2M average annual rent, and facility was operating at a loss. Not large relative to future? No. Another: New contracts with government partners for Northeast Ohio and Crossroads to replace expiring Marshal contracts. Those are new contractual arrangements with other government partners. But are they "recently obtained permission/access"? They are new contracts to operate facilities for various government partners. First business already flowing? Yes, they entered into new contractual arrangements in first half of year. But is most of what access permits still ahead? Probably not; these are existing facilities with ongoing operations. Not clear. Another: Arizona procurement for up to 2,700 beds. They responded to RFP, optimistic in contract award near end of year. That's pending, not obtained. Another: Hawaii - anticipate procurement in 2022, still pending. Another: West Tennessee - contract expired, pursuing procurement, not obtained. Another: Leavenworth - discussions with potential partners, not obtained. Another: ICE Title 42 - if lifted, surge in need, but not obtained.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| RDCM | RADCOM Ltd. | Q4 2023 | 2024-01-31 | A |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| NVAX | Novavax, Inc. | Q3 2023 | 2023-11-09 | F |
| RVLV | Revolve Group, Inc. | Q3 2023 | 2023-11-01 | C |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| CMLS | Cumulus Media Inc. | Q3 2022 | 2022-10-28 | D |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| CDXC | ChromaDex Corporation | Q4 2021 | 2022-03-09 | C+ |
| VNDA | Vanda Pharmaceuticals Inc. | Q4 2021 | 2022-02-23 | F |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| AMGN | Amgen Inc. | Q3 2018 | 2018-10-30 | B+ |
| MAS | Masco Corporation | Q3 2018 | 2018-10-30 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| BIIB | Biogen Inc. | Q2 2017 | 2017-07-25 | B |
| CNS | Cohen & Steers, Inc. | Q2 2017 | 2017-07-20 | B |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| PDCO | Patterson Companies, Inc. | Q3 2017 | 2017-02-23 | C |
| BMY | Bristol-Myers Squibb Company | Q4 2016 | 2017-01-26 | F |
| MAT | Mattel, Inc. | Q3 2016 | 2016-10-19 | C |
NVAX · Q3 2023 → YESThe question is: Does management describe that the company RECENTLY OBTAINED A PERMISSION, APPROVAL, QUALIFICATION, CERTIFICATION, LISTING, OR ACCESS RIGHT it did not previously hold — something grant...NO The transcript describes shipments of the updated COVID vaccine that began three weeks ago in the US after competitor launches, along with EU approval in October. However, these details do not meet the criteria for a YES answer because the transcript does not explicitly frame this as a newly obtained permission or access right that the company did not previously hold. Instead, it presents the launch as an update to their existing COVID-19 vaccine platform, with references to prior versions and the ability to update for seasonal strains.
MAT · Q3 2016 → YESThe question is about whether management describes that the company recently obtained a permission, approval, etc., that it didn't previously hold, and that real first business through that newly open...YES The transcript shows management describing a recent new partnership with Toys "R" Us for American Girl, granting exclusive store-within-store access that previously excluded the company. Initial shipping began in the first full quarter, with the distribution build still in early stages and most of the market potential ahead.
MAS · Q3 2018 → YESThe question is about whether management describes that the company recently obtained a permission, approval, etc., that it didn't previously hold, and that real first business through that newly open...YES The transcript shows management describing a recent program access at Menards that enables sales of stock cabinetry, with initial performance already underway and ramping toward an $80 million annual run rate in Q4—indicating the door is newly open and most of the potential volume remains ahead.